Life Sciences Capital Outlook: 2025 Review & 2026 Forecast
Join NEVCA for a candid, interactive breakfast conversation with leading investors and decision-makers in life sciences. Together, we’ll reflect on lessons learned from 2025, unpack the macro environment shaping today’s market, and look ahead to 2026.
Guided by seasoned general partners and industry leaders, the discussion will cover:
Fundraising & Capital Flows: Current trends, LP dynamics, and strategies for emerging managers.
Macro Environment: Policy, public markets, and global forces impacting biotech investment.
Year in Review & Outlook: Key takeaways from 2025 and what’s on the horizon for 2026.
This is not a sit-back speaker event. It’s an opportunity to share insights, test assumptions, and connect with peers across investment roles at life science venture firms across the region.
Event Details
📍 Location: USQ (10 Prospect St., Somerville, MA)
📅 Date: Tuesday, December 2
🕗 Time: 8:00 – 10:00 AM ET
8:00 – 8:30 AM: Coffee, breakfast, networking
8:30 – 9:30 AM: Investor roundtable & audience exchange
9:30 – 10:00 AM: Continued conversation over coffee
Roundtable Guides
Deborah Palestrant, Partner, 5AM Ventures
Deb Palestrant brings over 20 years of experience spanning drug discovery, company creation, operations, business development, and strategy. She serves on the boards of Latigo Biotherapeutics, Nido Biosciences, the New England Venture Capital Association, and Life Science Cares. Her career includes leadership roles at Relay Therapeutics, Editas Medicine, and Third Rock Ventures, where she helped launch Blueprint Medicines and Editas Medicine.
Stefan Vitorovic, Independent Investor
Stefan Vitorovic is an experienced life science investor, entrepreneur, and advisor. He co-founded and served as Managing Director at Vida Ventures, where he helped build and support a portfolio of innovative biotech companies. Earlier in his career, he was a Principal at Third Rock Ventures and an Associate at TPG Capital, contributing to investments in companies such as Tectonic Therapeutic and Allogene Therapeutics. Today, Stefan works independently with emerging and established life science companies, bringing strategic insight and deep sector expertise to each engagement.
Event Sponsors
With thanks to our host and sponsor, USQ, for supporting this conversation. USQ is revitalizing 20 acres in Union Square, Somerville, MA into a vibrant 3.8M SF mixed-use employment district. With new lab and office space, housing, retail, and green and open space, USQ will expand the Boston innovation ecosystem by fostering the next great concentration of life science and technology companies.
Please request to join on this page, and we will reach out upon approval of your attendance. Note that space is limited, and we may not be able to accept everyone.
By registering for this event, you grant the NEVCA permission to use your image or likeness in photographs, film, and quotations in promotional material and content.